A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Clinical trial NCT07009457 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07009457
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2027-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.